Lansoprazole triple therapy on peptic ulcer combined efficacy of Hp infection.docVIP

 PAGE \* MERGEFORMAT 7 Lansoprazole triple therapy on peptic ulcer combined efficacy of Hp infection Of: Tang Meisen Li Mingming Panghai Jiang [Abstract] Objective To observe the Chalansuola yl triple therapy of Helicobacter pylori (Hp and treatment of duodenal ulcer. Methods 66 patients with Hp-positive duodenal ulcer patients were divided into three groups: A, B, C group, triple therapy with lansoprazole. Results 58 patients completed the full treatment, 8 patients were lost. three Hp eradication rate 88.88% ~ 94.73%, group no significant difference (Pgt; 0.05. ulcer healing rates 83.33% ~ 89.43%, difference between groups was not significant (Pgt; 0.05. symptom score improvement among the three groups in pairs had significant differences (P lt;0.05). Conclusion The three programs are effective in eradicating Hp and promote ulcer healing. [Keywords:] lansoprazole triple therapy for Helicobacter pylori in duodenal ulcer Helicobacter pylori (Hp infection is the incidence of peptic ulcer of the most important factor. The past two decades of studies have shown that eradication of Hp can duodenal ulcer, gastric ulcer recurrence rate to 5% [ 1]. In this study, acid treatment at different under the concept of joint Chalansuola yl amoxicillin and clarithromycin treatment of Hp-positive duodenal ulcer effect. 1 Materials and Methods 1.1 General information on all the observed objects were taken from 66 patients with hospital outpatient cases, 39 males and 27 females, aged 18 to 70 years, mean 34.7 years, all the observed cases to 1 week before treatment confirmed by endoscopy Hp-positive activity in patients with duodenal ulcer, ulcer number of ≤ 2 个, size lt;1.5cm, 1 week is not used in other H2 receptor antagonists, anticholinergic drugs, antispasmodic drugs and other drugs in gastrointestinal function, no heart, lung, kidney dysfunction. 1.2 according to the treatment regimen selected by the order were randomly divided into three